Repositioning metformin and propranolol for colorectal and triple negative breast cancers treatment

Drug repositioning refers to new uses for existing drugs outside the scope of the original medical indications. This approach fastens the process of drug development allowing finding effective drugs with reduced side effects and lower costs. Colorectal cancer (CRC) is often diagnosed at advanced sta...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Sci Rep
Auteurs principaux: Anselmino, L. E., Baglioni, M. V., Malizia, F., Laluce, N. Cesatti, Etichetti, C. Borini, Marignac, V. L. Martínez, Rozados, V., Scharovsky, O. G., Girardini, J., Rico, M. J., Menacho Márquez, M.
Format: Artigo
Langue:Inglês
Publié: Nature Publishing Group UK 2021
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC8047046/
https://ncbi.nlm.nih.gov/pubmed/33854147
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-021-87525-z
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires